Carl Icahn Sells Biogen Idec (BIIB) Shares

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 7/11/2026

May 23, 2011 5:08 PM EDT

Price: $111.49 +0.69%

Overall Analyst Rating:
SELL (= Flat)

In 13D filing after the close, Carl Icahn disclosed the sale of some Biogen Idec Inc. (Nasdaq: BIIB) shares.

Top Hedge Fund Trades- FREE TRIAL!

Carl Icahn, 13D

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!